Abstract

Mistletoe (Viscum album L., VA) therapy has been applied in integrative oncology for over a century to support health-related quality of life in cancer patients. While early data were heterogeneous, recent systematic reviews, randomized controlled trials (RCTs), and real-world data (RWD) provide a more robust picture.